629551

Akorn, Inc. — FEI 3003102962

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 10, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gurnee, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings